Clinical Trial Designs for Predictive Biomarker Validation: One Size Does Not Fit All

By Mandrekar Sumithra   Sargent Daniel  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 3, 2009-05 ,pp. : 530-542

Taylor & Francis Ltd

Access to resources Recommend Favorite

Impact of biomarkers on clinical trial risk

By Reid Geoffrey Gilbert John   Bin Yameen Tarek Abdullah   Parker Jayson Lee  

Pharmacogenomics, Vol. 14, Iss. 13, 2013-10 ,pp. : 1645-1658

Future Medicine

Access to resources Recommend Favorite

Modifying Clinical Trial Designs to Test Treatments for Clinical Significance in Individual Patients

By Becker R.E.  

Clinical Drug Investigation, Vol. 21, Iss. 10, 2001-10 ,pp. : 727-733

Adis International

Access to resources Recommend Favorite

Pramipexole in Routine Clinical Practice: A Prospective Observational Trial in Parkinson's Disease

By Reichmann H.  

CNS Drugs, Vol. 17, Iss. 13, 2003-01 ,pp. : 965-973

Adis International

Access to resources Recommend Favorite

Application of Clinical Trial Simulation to Compare Proof-of-Concept Study Designs for Drugs with a Slow Onset of Effect; An Example in Alzheimer's Disease

By Lockwood Peter   Ewy Wayne   Hermann David   Holford Nick  

Pharmaceutical Research, Vol. 23, Iss. 9, 2006-09 ,pp. : 2050-2059

Springer Publishing Company

Access to resources Recommend Favorite